Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacy and Pharmacology|November 8, 2001
Effect of herbal teas on hepatic drug metabolizing enzymes in ratsP P Maliakal, S Wanwimolruk
The Journal of the Royal College of Physicians of Edinburgh|September 28, 2011
Central pontine myelinolysis without hyponatraemiaP Bose, A Kunnacherry, P Maliakal
The Journal of Pharmacy and Pharmacology|May 9, 2001
Tea consumption modulates hepatic drug metabolizing enzymes in Wistar ratsP P Maliakal, P F Coville, S Wanwimolruk
Drug Metabolism and Drug Interactions|September 12, 2002
Decreased hepatic drug metabolising enzyme activity in rats with nitrosamine-induced tumoursP P Maliakal, P F Coville, S Wanwimolruk
European Journal of Clinical Pharmacology|June 22, 2001
Oral quinine pharmacokinetics and dietary salt intakeP Newton, A Simpson, S Wanwimolruk, et al.
Clinical Radiology|January 13, 2026
The Hull mechanical thrombectomy (MT) model: interventional radiologists performing mechanical thrombectomy for acute ischaemic stroke in the United Kingdom. Training, governance and beyond, with a propensity score matching analysis of outcomesC Igwe, T Edwards, N Cinti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid TumorsAlexander N Starodub, Allyson J Ocean, Manish A Shah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trialK Kalinsky, J R Diamond, L T Vahdat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab GovitecanJhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
Pageof 1